title: Cost-effectiveness analysis of gestational diabetes mellitus screening in France.
abstract: OBJECTIVE
  To compare three strategies for gestational diabetes screening (i) screening of high-risk pregnant women with the 50 g oral glucose tolerance test (OGTT); (ii) screening of all pregnant women with the 50 g OGTT; (iii) screening of all pregnant women according to the 75 g OGTT.
  
  
  METHODS
  Cost-effectiveness analysis. The outcome measures, i.e. macrosomia, prematurity, perinatal mortality, hypertensive disorders rates were estimated from published studies and the costs from a prospective study involving 120 pregnant women.
  
  
  RESULTS
  Compared to the first strategy, the cost to obtain one unit of additional effectiveness with the second screening strategy, was up to 1.1 times more expensive, and with the third strategy was up to 3.7 times more expensive.
  
  
  CONCLUSIONS
  The costs per case prevented reflect a favourable cost-effectiveness ratio (CER) for screening of high-risk pregnant women by 50 g oral glucose test.
authors.affiliation: Unité d'évaluation médico-économique, Département d'Information Médicale, Hospices Civils de Lyon, LASS-UMR 5823 CNRS, 162 Avenue Lacassagne, 69424 Cedex 03, Lyon, France. benedicte.poncet@chu-lyon.fr
authors.forename: Bénédicte
authors.initials: B
authors.lastname: Poncet
authors.forename: Sandrine
authors.initials: S
authors.lastname: Touzet
authors.forename: Laure
authors.initials: L
authors.lastname: Rocher
authors.forename: Michel
authors.initials: M
authors.lastname: Berland
authors.forename: Jacques
authors.initials: J
authors.lastname: Orgiazzi
authors.forename: Cyrille
authors.initials: C
authors.lastname: Colin
mesh_terms: D003362:Cost-Benefit Analysis; D016640:Diabetes, Gestational / Q000175:diagnosis* / Q000453:epidemiology; D005260:Female; D005320:Fetal Macrosomia / Q000453:epidemiology / Q000517:prevention & control; D005602:France / Q000453:epidemiology; D005951:Glucose Tolerance Test / Q000191:economics; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D008403:Mass Screening / Q000191:economics*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control; D011446:Prospective Studies; D012307:Risk Factors